NCT00564668View on ClinicalTrials.gov

Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

June 19, 2004

Primary Completion Date

April 12, 2005

Study Completion Date

April 12, 2005

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY